Chlamydia

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
1 program
Chlamydia, gonorrhea, syphilis, and HIV screeningN/A1 trial
Active Trials
NCT06428643Not Yet RecruitingEst. Sep 2029

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
2029
Allergy TherapeuticsChlamydia, gonorrhea, syphilis, and HIV screening

Clinical Trials (1)

NCT06428643Allergy TherapeuticsChlamydia, gonorrhea, syphilis, and HIV screening

A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities

Start: Sep 2024Est. completion: Sep 2029
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space